Rosuvastatin Tablet, Film Coated
Product Images NDC 50090-7241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 50090-7241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
This is a statistical analysis output presenting data on RSV and Placebo groups including the number at risk and years of observation. The data includes results such as hazard ratio, confidence interval, p-value, and the number of participants in each group over time.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
This text presents a comparison of the efficacy of Rosuvastatin 20 mg versus Placebo 20 mg in reducing cardiovascular events. It includes data on primary endpoints, cardiovascular death, non-fatal stroke, non-fatal MI, hospitalized unstable angina, and arterial revascularization. The results show hazard ratios with confidence intervals and p-values, indicating the statistical significance of the findings. Overall, the study suggests that Rosuvastatin 20 mg may be effective in reducing cardiovascular events compared to placebo.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
FDA Label Image

Label Image (Lbl500907241)

Label Image (Lbl500907241)
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.